Program Details
Friday, 30 Oct 2020
Room 1
| The Heart Failure Patient from Implant to Remote Follow-up in 2020 & Beyond | ||
| 09:30 - 10:30 | Chairman: Swee-Chong SEOW (Singapore) | |
| CRT implant tips and tricks | Katherine FAN (Hong Kong) | |
| Post CRT implant, managing your heart failure patients remotely in 2020 and beyond | Grant SHALABY (Australia) | |
| Market Access for Arrhythmia Management | ||
| 10:50 - 12:20 | Chairman: Jayaprakash SHENTHAR (India) | |
| Skill building: Best practices to enhance skill level of cardiologists in India | V S PRAKASH (India) Arun CHOPRA (India) | |
| Care pathway: best practices to resolve broken patient pathway in the continuum of care | Anil SAXENA (India) Ajay NAIK (India) Ajit THACHIL (India) | |
| Reimbursement: universal health scheme – Are we addressing the unmet health needs yet? | Nitish NAIK (India) N NAMBOODIRI (India) | |
| Market Apt products:- Accelerate innovations to bring products/services for the emerging markets | Dilip KUMAR (India) Arun GOPI (India) | |
| His-Purkinje System Pacing | ||
| 12:40 - 14:10 | Chairmans: Wei HUA (China) | |
| Swee-Chong SEOW (Singapore) | ||
| Tarlochan KLER (India) | ||
| Weijian HUANG (China) | ||
| How to confirm the capture the left bundle branch pacing | Weijian HUANG (China) | |
| Left bundle branch pacing: characteristics and implant skills | Keping CHEN | |
| Cardiac resynchronization by His bundle pacing and role of HOT CRT | Narasimhan CALAMBUR (India) | |
| His bundle pacing vs left bundle branch area pacing – when & why | Ulhas PANDURANGI (India) | |
| Conduction system pacing – Single center experience | Shunmuga Sundaram PONNUSAMY (India) | |
| Singapore single center experience (Interesting case sharing) | Pipin KOJODJOJO (Singapore) | |
| Novel approach to left bundle branch pacing | Jiangang ZOU (China) | |
| How Safe is NOAC? Evidence of Real World Experience | ||
| 14:30 - 16:00 | Chairmans: Wee-Siong TEO (Singapore) | |
| Chen-Chuan CHENG (Taiwan) | ||
| Kok-Wei KOH (Malaysia) | ||
| Optimize your AF patient journey: World evidence of NOAC and updates of HK local registry | Chung-Wah SIU (Hong Kong) | |
| Renal outcome of NOAC: An Asian perspective | Alex Pui-Wai LEE (Hong Kong) | |
| From trials to practices: The importance of reversal strategy on NOAC | Martin STILES (New Zealand) | |
| Advancing S-ICD through Clinical Evidence & Contemporary Implant Management in Asia Pacific | ||
| 16:20 - 17:50 | Chairmans: Wei HUA (China) | |
| Bo-Young JOUNG (Republic of Korea) | ||
| The PRAETORIAN trial; S-ICD vs TV-ICD 4-year results of the landmark head-to-head study | Reinoud KNOPS (Netherlands) | |
| UNTOUCHED data; safety and efficacy in primary prevention patients with low EF | Michael GOLD (USA) | |
| The current landscape of S-ICD in Asia Pacific | Hung-Fat TSE (Hong Kong) | |
| Tips and tricks for the optimal S-ICD implantation in the Asian patient | Hiroshi NAKAJIMA (Japan) | |
( Updated as of 23 Oct 2020 )
Remark: The above programs are subject to change without prior notice.